✦ LIBER ✦
713 ORAL Interruption of Imatinib (IM) in responding patients after one year treatment does not influence overall survival of patients with advanced GIST: Updated results of the French Sarcoma Group randomized phase III BFR14 trial
- Book ID
- 118623289
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 144 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.